Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (4052)	6/4/2000 12:07:00 PM
From: chirodoc	Read Replies (1) \| Respond to of 6039

THE COMPETITION about a year ago, omnicorder claimed two clinical sites in upstate new york where they were doing trials and then claimed they would ipo about 6 months ago. the ipo never happened and their webiste NO LONGER LISTS ANY SITES FOR CLINICAL TRIALS (you check it out--i could not find them anymore). in my opinion, with their claims that they have an approved system for breast cancer, they are a minor league group that will be no competition. i would not be surprised if the fda were investigating their claims at some point. here is the website: omnicorder.com dynamics imaging (DOBI) is in trials. however, the effectiveness is questionable (less effective than coii at last published study) and involves the woman standing and having her breast squeezed in a pneumatic device while it is scanned. they are at least in trials. here is their website: dynamicsimaging.com it is coii's race to lose at this point. a one year head start is huge in a field like this. coii will be on to back and neck pain before the first competitor is approved for breast cancer. curtis